Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial Evaluating the Efficacy and Safety of Uracil 0,5% Plasters in Oncology Patients Affected by Hand-foot Syndrome (HFS)
Sponsor: Wooshin Labottach Co., Ltd.
Summary
The goal of this clinical trial is to learn if The Uracil plaster works to treat mild HFS in adults under chemiotherapy. It will also learn about the safety . The main questions it aims to answer are: Does Uracil Plaster lower the number of days participants need to reduce the HFS symptoms? What medical problems do participants have when using the Uracil plaster MD? Researchers will compare the Uracil plaster to a standard lenitive cream to see if Uracil Plaster works better to treat mild HFS. Participants will: Use the plaster or the cream 2/3 times day for 3 weeks Visit the hospital once every week for checkups and tests Keep a diary of their symptoms and the number of times they use the therapy
Official title: A Randomized, Single Blind, Parallel Groups, Clinical Trial Evaluating the Efficacy and Safety of Uracil 0,5%-Containing Plasters Versus "Lenitive Cream", in Oncology Patients Affected by Hand-foot Syndrome (HFS)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-07
Completion Date
2027-04
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
Uracil 0,5% plasters
Patients will applicate to hands and feet the plaster twice per day for 3 weeks to reduce the HFS grade.
lenitive cream
Patients will applicate the cream 3 times per day for 3 weeks to compare the change of HFS severity
Locations (1)
Presidio Ospedaliero Di Rho - Asst Rhodense- Oncology Department
Rho, MI, Italy